BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 296653)

  • 1. Ocular complications following blast transformation in chronic myelogenous leukemia.
    Hendrick AM; Rogers JS; Guliner RJ
    Am J Hematol; 1979; 7(4):389-94. PubMed ID: 296653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An adult case of chronic myelogenous leukemia with myeloblastic involvement of the central nervous system.
    Watanabe A; Hattori S; Sato Y; Nagashima H; Kitajima K
    Acta Med Okayama; 1984 Jun; 38(3):269-74. PubMed ID: 6589953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-blastic meningeal leukemia during the myelofibrotic phase of chronic myeloid leukemia.
    Aversa P; Rambotti P; Falini B; Grignani F; Martelli MF
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):72-5. PubMed ID: 6164616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LEUKEMIC OPTIC NERVE INFILTRATION IN A PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA.
    Nagpal MP; Mehrotra NS; Mehta RC; Shukla CK
    Retin Cases Brief Rep; 2016; 10(2):127-30. PubMed ID: 26267525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia cutis in blastic transformation of chronic myelocytic leukemia: TdT positive blasts and response to vincristine and prednisone.
    Ansell JE; Bhawan J; Pechet L
    J Cutan Pathol; 1980 Oct; 7(5):302-9. PubMed ID: 6933170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive retinal infiltrates as the presenting sign of chronic myeloid leukemia: Clinical and imaging features of leukemic retinopathy.
    Szeto SK; Mohamed S; Tsang CW; Chan CK
    Eur J Ophthalmol; 2023 Jan; 33(1):NP55-NP63. PubMed ID: 34595942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reversible visual impairment caused by leukemic fundus changes (author's transl)].
    Moser E
    Klin Monbl Augenheilkd; 1979 Feb; 174(2):240-2. PubMed ID: 286131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ocular manifestations in chronic myeloid leukemia].
    Nuţă M; Popa DP; Cristea E
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1980; 24(1):17-9. PubMed ID: 6447888
    [No Abstract]   [Full Text] [Related]  

  • 9. Retinal abnormalities in diseases of the blood.
    Holt JM; Gordon-Smith EC
    Br J Ophthalmol; 1969 Mar; 53(3):145-60. PubMed ID: 5252200
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocular manifestations of leukemia. A review.
    Rosenthal AR
    Ophthalmology; 1983 Aug; 90(8):899-905. PubMed ID: 6195573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system involvement at presentation in the chronic phase of chronic myelogenous leukemia in childhood.
    Meyer RJ; Cuttner J
    Cancer; 1978 Jul; 42(1):305-10. PubMed ID: 276416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis.
    Iacoboni SJ; Plunkett W; Kantarjian HM; Estey E; Keating MJ; McCredie KB; Freireich EJ
    J Clin Oncol; 1986 Jul; 4(7):1079-88. PubMed ID: 3459811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral retinal neovascularization with chronic myelogenous leukemia.
    Frank RN; Ryan SJ
    Arch Ophthalmol; 1972 May; 87(5):585-9. PubMed ID: 4503298
    [No Abstract]   [Full Text] [Related]  

  • 14. An autopsy study of eye involvement in acute leukemia of childhood.
    Robb RM; Ervin LD; Sallan SE
    Med Pediatr Oncol; 1979; 6(2):171-7. PubMed ID: 287857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular manifestations of leukaemia.
    Kumar D; Singh VP; Thakur V; Neema HV; Das SK
    Indian J Cancer; 1983; 20(1):35-7. PubMed ID: 6574103
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ocular symptoms and leukemia in childhood].
    Krebs W; Metz O; Plenert W
    Klin Monbl Augenheilkd; 1982 Nov; 181(5):407-8. PubMed ID: 7162098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy of chronic myelogenous leukemia in blastic crisis--vindesine, cytosine arabinoside prednisolone combination therapy].
    Uzuka Y; Saito Y; Takahash H; Komatsu M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1064-70. PubMed ID: 6586112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of chronic myelogenous leukemia in blastic crisis with the chemotherapy incorporating vindesine-prednisolone.
    Saito Y; Uzuka Y; Takahashi H; Komatsu M; Ito T
    Tohoku J Exp Med; 1986 Jan; 148(1):65-72. PubMed ID: 3458333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. White-centred retinal hemorrhage revealing acute leukemia.
    Chaabani L; Doulami K
    Tunis Med; 2019 Jun; 97(6):822-825. PubMed ID: 31872415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningeal leukemia after blastic transformation of chronic myeloid leukemia.
    Atkinson K; Kay HE; Lawler SD; Wells DG; McElwain TJ
    Cancer; 1975 Feb; 35(2):529-33. PubMed ID: 1053938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.